Genesee Capital Advisors, LLC Amgen Inc Transaction History

Genesee Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $18,552 - $22,394	-69 Reduced 1.96%	3,456 $982,000
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $901,342 - $1.02 Million	3,525 New	3,525 $1.02 Million
Q4 2020 Jan 19, 2021	SELL	$216.38 - $257.67 $750,838 - $894,114	-3,470 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $6,335 - $7,045	27 Added 0.78%	3,470 $881,000
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $72,002 - $88,357	-364 Reduced 9.56%	3,443 $812,000
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $693,787 - $920,151	3,807 New	3,807 $771,000

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Genesee Capital Advisors, LLC with notifications on news.